{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:34:36Z","timestamp":1795196076448,"version":"4.10.3"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) is a common condition characterized by reproductive, hyperandrogenic and dysmetabolic features, and often becomes clinically manifest during adolescence, particularly with weight-gain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Sources of data<\/jats:title>\n                  <jats:p>Pubmed search.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Areas of agreement<\/jats:title>\n                  <jats:p>PCOS is heritable and closely associates with obesity (based on data from both epidemiological and genetic studies). Furthermore, insulin resistance forms a central cornerstone of the pathogenesis of PCOS and mediates a close association between obesity and the severity of the phenotypic features of PCOS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Areas of controversy<\/jats:title>\n                  <jats:p>Our understanding of the pathogenesis of PCOS remains incomplete, especially regarding its missing heritability (with only a small fraction having been identified from the genome-wide association studies reported to date), and its developmental origins.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Growing points<\/jats:title>\n                  <jats:p>A challenge for the future is to explore a role for epigenetic modifications in the development of PCOS, and implications for the in utero environment and novel therapeutic opportunities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bmb\/ldac007","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T12:10:29Z","timestamp":1645791029000},"page":"4-15","source":"Crossref","is-referenced-by-count":40,"title":["Why are women with polycystic ovary syndrome obese?"],"prefix":"10.1093","volume":"143","author":[{"given":"T M","family":"Barber","sequence":"first","affiliation":[{"name":"Division of Biomedical Sciences , Warwick Medical School, , Clifford Bridge Road, Coventry CV2 2DX, UK"},{"name":"University of Warwick, Clinical Sciences Research Laboratories, University Hospitals Coventry and Warwickshire , Warwick Medical School, , Clifford Bridge Road, Coventry CV2 2DX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,12]]},"reference":[{"key":"2022092209092430700_ref1","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2022092209092430700_ref2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","article-title":"Obesity and polycystic ovary syndrome","volume":"65","author":"Barber","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022092209092430700_ref3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","journal-title":"Hum Reprod"},{"key":"2022092209092430700_ref4","first-page":"34","article-title":"Metabolic syndrome in polycystic ovary syndrome","volume":"58","author":"Barber","year":"2007","journal-title":"Endokrynol Pol"},{"key":"2022092209092430700_ref5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/cen.14421","article-title":"Obesity and polycystic ovary syndrome","volume":"95","author":"Barber","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022092209092430700_ref6","doi-asserted-by":"crossref","first-page":"s72","DOI":"10.7861\/clinmedicine.15-6-s72","article-title":"Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance","volume":"15","author":"Barber","year":"2015","journal-title":"Clin Med (Lond)"},{"key":"2022092209092430700_ref7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2265.2011.03983.x","article-title":"Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters","volume":"74","author":"Joharatnam","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022092209092430700_ref8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/jc.2015-3543","article-title":"Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study","volume":"101","author":"Ollila","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2022092209092430700_ref9","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2022092209092430700_ref10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/eem.10.32","article-title":"Genetic basis of polycystic ovary syndrome","volume":"5","author":"Barber","year":"2010","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2022092209092430700_ref11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000341682","article-title":"Genetics of polycystic ovary syndrome","volume":"40","author":"Barber","year":"2013","journal-title":"Front Horm Res"},{"key":"2022092209092430700_ref12","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2022092209092430700_ref13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00125-008-1028-6","article-title":"Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome","volume":"51","author":"Barber","year":"2008","journal-title":"Diabetologia"},{"key":"2022092209092430700_ref14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2008.06.039","article-title":"FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome","volume":"373","author":"Attaoua","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2022092209092430700_ref15","doi-asserted-by":"crossref","first-page":"e16390","DOI":"10.1371\/journal.pone.0016390","article-title":"FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome","volume":"6","author":"Ewens","year":"2011","journal-title":"PLoS One"},{"key":"2022092209092430700_ref16","doi-asserted-by":"crossref","first-page":"E1342","DOI":"10.1210\/jc.2011-3478","article-title":"Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry","volume":"97","author":"Welt","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2022092209092430700_ref17","doi-asserted-by":"crossref","first-page":"E185","DOI":"10.1210\/jc.2012-2471","article-title":"Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry","volume":"98","author":"Mutharasan","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2022092209092430700_ref18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jmedgenet-2011-100427","article-title":"Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts","volume":"49","author":"Goodarzi","year":"2012","journal-title":"J Med Genet"},{"key":"2022092209092430700_ref19","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1038\/ncomms8502","article-title":"Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat Commun"},{"key":"2022092209092430700_ref20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"2022092209092430700_ref21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.2384","article-title":"Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome","volume":"44","author":"Shi","year":"2012","journal-title":"Nat Genet"},{"key":"2022092209092430700_ref22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/humrep\/dey343","article-title":"Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome","volume":"34","author":"Brower","year":"2019","journal-title":"Hum Reprod"},{"key":"2022092209092430700_ref23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/rp.56.1.295","article-title":"Insulin resistance in polycystic ovary syndrome: progress and paradoxes","volume":"56","author":"Venkatesan","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"2022092209092430700_ref24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000323395","article-title":"Insulin resistance: pathophysiology and rationale for treatment","volume":"58","author":"Muntoni","year":"2011","journal-title":"Ann Nutr Metab"},{"key":"2022092209092430700_ref25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1373\/clinchem.2005.048611","article-title":"The metabolic syndrome: requiescat in pace","volume":"51","author":"Reaven","year":"2005","journal-title":"Clin Chem"},{"key":"2022092209092430700_ref26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/humrep\/deh609","article-title":"Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries","volume":"20","author":"Rice","year":"2005","journal-title":"Hum Reprod"},{"key":"2022092209092430700_ref27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2012.10.010","article-title":"Adipocyte biology in polycystic ovary syndrome","volume":"373","author":"Barber","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2022092209092430700_ref28","first-page":"183","volume-title":"Mechanisms of Anovulation in Polycystic Ovary Syndrome","author":"Franks","year":"1996"},{"key":"2022092209092430700_ref29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2265.1995.tb02665.x","article-title":"Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome","volume":"42","author":"White","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022092209092430700_ref30","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/humrep\/15.6.1266","article-title":"Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome","volume":"15","author":"Morin-Papunen","year":"2000","journal-title":"Hum Reprod"},{"key":"2022092209092430700_ref31","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"2022092209092430700_ref32","doi-asserted-by":"crossref","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet"},{"key":"2022092209092430700_ref33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fendo.2020.00274","article-title":"PCOS-GWAS susceptibility variants in THADA, INSR, TOX3, and DENND1A are associated with metabolic syndrome or insulin resistance in women with PCOS","volume":"11","author":"Tian","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022092209092430700_ref34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.acc.2015.06.001","article-title":"Polycystic ovary syndrome-epigenetic mechanisms and aberrant MicroRNA","volume":"71","author":"Ilie","year":"2015","journal-title":"Adv Clin Chem"},{"key":"2022092209092430700_ref35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbagrm.2010.05.005","article-title":"Interplay between microRNAs and the epigenetic machinery: an intricate network","volume":"1799","author":"Iorio","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2022092209092430700_ref36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ Res"},{"key":"2022092209092430700_ref37","doi-asserted-by":"crossref","first-page":"110611","DOI":"10.1016\/j.mce.2019.110611","article-title":"Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS)","volume":"500","author":"Makrinou","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"2022092209092430700_ref38","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4239\/wjd.v6.i7.936","article-title":"Fetal programming of polycystic ovary syndrome","volume":"6","author":"Gur","year":"2015","journal-title":"World J Diabetes"},{"key":"2022092209092430700_ref39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum Reprod Update"},{"key":"2022092209092430700_ref40","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1095\/biolreprod.102.015164","article-title":"Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving follicle-stimulating hormone therapy for in vitro fertilization","volume":"69","author":"Dumesic","year":"2003","journal-title":"Biol Reprod"},{"key":"2022092209092430700_ref41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat Med"},{"key":"2022092209092430700_ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome - a hypothesis","volume":"174","author":"Abbott","year":"2002","journal-title":"J Endocrinol"},{"key":"2022092209092430700_ref43","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","article-title":"Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome","volume":"25","author":"Risal","year":"2019","journal-title":"Nat Med"},{"key":"2022092209092430700_ref44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1071\/RD04092","article-title":"Early origins of polycystic ovary syndrome","volume":"17","author":"Dumesic","year":"2005","journal-title":"Reprod Fertil Dev"},{"key":"2022092209092430700_ref45","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/oby.23177","article-title":"Association of Visceral Adipose Tissue and Insulin Resistance with incident metabolic syndrome independent of obesity status: the IRAS family study","volume":"29","author":"Mongraw-Chaffin","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"2022092209092430700_ref46","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2007-2117","article-title":"Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome","volume":"93","author":"Barber","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["British Medical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bmb\/article-pdf\/143\/1\/4\/45972100\/ldac007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bmb\/article-pdf\/143\/1\/4\/45972100\/ldac007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T09:19:01Z","timestamp":1663838341000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bmb\/article\/143\/1\/4\/6547855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3,12]]},"published-print":{"date-parts":[[2022,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/bmb\/ldac007","relation":{},"ISSN":["0007-1420","1471-8391"],"issn-type":[{"value":"0007-1420","type":"print"},{"value":"1471-8391","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9]]},"published":{"date-parts":[[2022,3,12]]}}}